Pediatric patients with COVID-19 admitted to intensive care units in Brazil: a prospective multicenter study

Arnaldo Prata-Barbosa1, Fernanda Lima-Setta1, Gustavo Rodrigues Dos Santos1

  • 1Instituto D'Or de Pesquisa e Ensino (IDOR), Rio de Janeiro, RJ, Brazil.

Jornal De Pediatria
|August 12, 2020
PubMed

Insights

In Brazilian pediatric intensive care units, COVID-19 had low mortality. Comorbidities, not age under one year, independently predicted severity in children and adolescents with COVID-19.

Area of Science:

  • Pediatric Intensive Care
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • COVID-19 affects children and adolescents, with some developing severe illness requiring intensive care.
  • Multisystemic Inflammatory Syndrome in Children (MIS-C) is a recognized complication of SARS-CoV-2 infection.
  • Understanding risk factors for severe COVID-19 in pediatric populations is crucial for clinical management.

Purpose of the Study:

  • To characterize clinical presentations and outcomes of pediatric patients admitted to intensive care with COVID-19.
  • To identify predictors of severity and invasive mechanical ventilation in this cohort.
  • To compare characteristics between patients with and without MIS-C.

Main Methods:

  • Prospective, multicenter observational study in 19 Brazilian pediatric intensive care units.
  • Inclusion of patients aged 1 month to 19 years admitted between March and May 2020.
  • Data collection on demographics, clinical features, treatments, and outcomes, with subgroup analyses and multivariable logistic regression for severity predictors.

Main Results:

  • Seventy-nine patients were included; 10 had MIS-C. Median age was 4 years; 41% had comorbidities.
  • Fever, cough, and tachypnea were common. MIS-C patients exhibited more severe symptoms, higher inflammatory markers, and more pleural effusions.
  • 18% required invasive mechanical ventilation; 3% mortality. Comorbidities were independently associated with ventilation need (OR 5.5).

Conclusions:

  • COVID-19 in Brazilian pediatric ICUs had low mortality.
  • Age under one year was not a predictor of worse prognosis.
  • Comorbidities and chronic diseases were independent predictors of severity, while MIS-C patients presented with more severe symptoms.
Abstract

Related Concept Videos

Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
637
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
859
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
340
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
597
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
154
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
175